Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases.

Saved in:
Bibliographic Details
Title: Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases.
Authors: Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USA., Nagar SP; Johnson & Johnson, Horsham, PA, USA., Ghosh S; Johnson & Johnson, Horsham, PA, USA., Fan L; Johnson & Johnson, Horsham, PA, USA., Alegria V; Johnson & Johnson, Horsham, PA, USA., De Braganca KC; Johnson & Johnson, Horsham, PA, USA., Lengil T; Johnson & Johnson, Raritan, NJ, USA., Sharma M; Johnson & Johnson, Raritan, NJ, USA., Pai H; Johnson & Johnson, Raritan, NJ, USA., Perciavalle M; Legend Biotech USA Inc, Somerset, NJ, USA., Maitland J; Analysis Group ULC, Toronto, ON, Canada., Emond B; Analysis Group ULC, Montreal, QC, Canada., Bixby T; Johnson & Johnson, Horsham, PA, USA., Qureshi ZP; Johnson & Johnson, Horsham, PA, USA. zquresh3@its.jnj.com., Fonseca R; Division of Hematology and Medical Oncology, Mayo Clinic in Arizona, Phoenix, AZ, USA.
Source: Oncology and therapy [Oncol Ther] 2026 Apr 18. Date of Electronic Publication: 2026 Apr 18.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first